Lv674
1760 积分 2026-04-29 加入
Personalized neoantigen-targeting cancer vaccines in ovarian cancer: a phase 1 trial
26天前
已完结
Efficient non-viral immune cell engineering using circular single-stranded DNA-mediated genomic integration
1个月前
已完结
Engineering cytokines for tumor-targeting and selective T cell activation
1个月前
已完结
Generating functionally stable and antigen-specific T reg cells from effector T cells for cell therapy of inflammatory diseases
1个月前
已完结
Conversion of pathogenic T cells into functionally stabilized T reg cells for antigen-specific immunosuppression in pemphigus vulgaris
1个月前
已完结
Non-clinical toxicology of therapeutic vaccines: Regulatory considerations and species selection: A comprehensive review
2个月前
已完结
肿瘤治疗性mRNA疫苗非临床评价的考虑
2个月前
已完结
SHR-2005, an FcγR-Dependent CD40 Agonistic Antibody with Potent Antitumor Activities and Favorable Safety Profile
4个月前
已完结
Co-blocking TIGIT and PVRIG Using a Novel Bispecific Antibody Enhances Antitumor Immunity
4个月前
已完结
Development of a Tumor-Specific Multivalent CD40 Agonist Antibody FAPxCD40 for Cancer Therapy: Balancing Efficacy and Toxicity
4个月前
已完结
皖公网安备34019202002308
